Genetic Leap harnesses the power of AI for precise and durable gene expression control with RNA-targeted molecules to target any disease epigenetically. Our groundbreaking gene therapy approach offers the efficacy of traditional methods with the safety and convenience of a pill. Since 2016, we've been at the forefront of using AI to revolutionize disease treatment, achieving unparalleled control over challenging targets like MYC and IL-2.

Through collaborations in Genetic Medicine and RNA-targeted small molecule design, we continue to push the boundaries of what is possible in genomic medicine. Join us on our mission to transform healthcare and improve lives. For inquiries or partnership opportunities, contact partner@genetic-leap.

com. Genetic Leap - Leading the way in precise gene control at the RNA level